Jennifer is the Head of Regulatory and Policy for FAST and Co-director of ABOM. She has worked in drug development for over 20 years, primarily focused on advancing global development programs for the treatment of rare neurological diseases. Her background and experience working with global regulatory agencies to support diverse drug and biological therapy development programs in both the development and post-marketing strategies will greatly benefit the FAST community. Jennifer resides in Danvers, MA. She has a niece, Samantha who lives with Angelman syndrome.